Sign inGet started

Morgenthaler Management Partners IX, LLC

Insider CIK 1666860 · VAPO 10% owner · RARX 10% owner · DOCS Director, 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
DOCS Doximity, Inc. J Other2021-11-122021-11-128,535,175— $08,535,175SEC↗
DOCS Doximity, Inc. C Conversion deriv2021-11-102021-11-1217,070,350— $00SEC↗
DOCS Doximity, Inc. C Conversion2021-11-102021-11-1217,070,350— $017,070,350SEC↗
DOCS Doximity, Inc. C Conversion deriv2021-06-282021-06-281,659,476— $00SEC↗
DOCS Doximity, Inc. C Conversion deriv2021-06-282021-06-2815,410,874— $00SEC↗
DOCS Doximity, Inc. C Conversion deriv2021-06-282021-06-2817,070,350— $017,070,350SEC↗
VAPO VAPOTHERM INC C Conversion deriv2018-11-162018-11-20359,842— $00SEC↗
VAPO VAPOTHERM INC C Conversion deriv2018-11-162018-11-20129,418— $00SEC↗
VAPO VAPOTHERM INC C Conversion deriv2018-11-162018-11-2061,342— $00SEC↗
VAPO VAPOTHERM INC C Conversion deriv2018-11-162018-11-20217,803— $00SEC↗
VAPO VAPOTHERM INC C Conversion deriv2018-11-162018-11-20214,285— $00SEC↗
VAPO VAPOTHERM INC C Conversion2018-11-162018-11-2061,342— $0982,690SEC↗
VAPO VAPOTHERM INC C Conversion2018-11-162018-11-20921,348— $0921,348SEC↗
RARX Ra Pharmaceuticals, Inc. C Conversion deriv2016-10-312016-10-313,664,071— $00SEC↗
RARX Ra Pharmaceuticals, Inc. C Conversion deriv2016-10-312016-10-319,744,916— $00SEC↗
RARX Ra Pharmaceuticals, Inc. C Conversion deriv2016-10-312016-10-313,408,439— $00SEC↗
RARX Ra Pharmaceuticals, Inc. X Exercise deriv2016-10-312016-10-3163,019— $00SEC↗
RARX Ra Pharmaceuticals, Inc. P Buy2016-10-312016-10-31263,538$13.00 $3.43M2,745,846SEC↗
RARX Ra Pharmaceuticals, Inc. X Exercise2016-10-312016-10-3163,019$0.07 $4.4K80,161SEC↗
RARX Ra Pharmaceuticals, Inc. S Sale2016-10-312016-10-31340$13.00 $4.4K79,821SEC↗
RARX Ra Pharmaceuticals, Inc. C Conversion2016-10-312016-10-31486,919— $02,482,308SEC↗
RARX Ra Pharmaceuticals, Inc. C Conversion2016-10-312016-10-31523,438— $01,995,389SEC↗
RARX Ra Pharmaceuticals, Inc. C Conversion2016-10-312016-10-311,392,130— $01,471,951SEC↗